SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech - Quaterly Results

25 Apr 2025 Evaluate
A decent increase of about 35.96% in the sales to Rs. 4266.53 millions was observed for the quarter ended March 2025. The sales figure stood at Rs. 3138.04 millions during the year-ago period.Profit saw a slight increase of 23.68%to Rs. 323.64  millions from Rs. 261.68 millions.OP of the company witnessed a marginal growth to 545.96 millions from 430.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4266.53 3138.04 35.96 14316.28 12029.10 19.01 14316.28 12029.10 19.01
Other Income 23.96 13.42 78.54 57.42 67.71 -15.20 57.42 67.71 -15.20
PBIDT 545.96 430.63 26.78 1919.77 1680.25 14.26 1919.77 1680.25 14.26
Interest 30.75 17.38 76.93 95.84 97.02 -1.22 95.84 97.02 -1.22
PBDT 515.21 413.25 24.67 1823.93 1583.23 15.20 1823.93 1583.23 15.20
Depreciation 76.63 65.80 16.46 276.90 241.89 14.47 276.90 241.89 14.47
PBT 438.58 347.45 26.23 1547.03 1341.34 15.33 1547.03 1341.34 15.33
TAX 114.94 85.77 34.01 399.61 344.89 15.87 399.61 344.89 15.87
Deferred Tax -8.57 1.70 -604.12 -22.25 -16.70 33.23 -22.25 -16.70 33.23
PAT 323.64 261.68 23.68 1147.42 996.45 15.15 1147.42 996.45 15.15
Equity 110.73 110.49 0.22 110.73 110.49 0.22 110.73 110.49 0.22
PBIDTM(%) 12.80 13.72 -6.75 13.41 13.97 -4.00 13.41 13.97 -4.00

Rossari Biotech Share Price

480.85 0.70 (0.15%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3628.65
Tata Chemicals 801.15
SRF 2527.60
Pidilite Inds. 1363.45
Deepak Nitrite 1771.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×